http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014121228-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bc5292a07e34d16eb1d033a16d3aec3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
filingDate 2014-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_568f64c9ad90378080a4ca459f1324ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b7f5afe4b3d3790319002bb679bd8ac
publicationDate 2014-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014121228-A1
titleOfInvention Methods of controlling vascularity using raver2 as a mediator for expression of vegf receptor sfit1
abstract Methods of treating a condition in a subject resulting from abnormally high VEGF signaling through membrane-bound receptors. Such a method can include increasing expression of Raver2 in affected cells of the subject to increase production of soluble VEGF receptors. In some aspects, increasing expression of Raver2 decreases production of membrane-bound VEGF receptors.
priorityDate 2013-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009181380-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127907945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128448067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423259
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18346235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129352157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23693948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127485728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226587093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID80006

Total number of triples: 35.